Senior insider sale
Principal Accounting Officer at MONTE ROSA THERAPEUTICS, INC. — senior position signals high conviction
$918.0K
51.96K shares
What this filing means
DUNN EDMUND plans to sell 51.96K shares of MONTE ROSA THERAPEUTICS, INC. valued at approximately $918.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/8/2026ACC: 0001950047-26-003308
Officer· Principal Accounting Officer
Since Mar 2026
51.96K
Shares to sell
$918.0K
Approx. market value
26.12K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
4/8/2026
26.12KTotal acquired26.12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/8/2026 | Stock Option Exercise Cash | 26.12K | — |
| Total | 26.12K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
139.00
Market value
$2.5K
3/4/2026
—Completed
Units to sell
536.00
Market value
$9.4K
3/2/2026
—Completed
Units to sell
25.16K
Market value
$455.5K
2/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
26.12K
Market value
$450.6K
4/8/2026
Total
Units
51.96K
Value
$918.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2026 | 139.00 | $2.5K | — | Completed |
3/2/2026 | 536.00 | $9.4K | — | Completed |
2/27/2026 | 25.16K | $455.5K | — | Completed |
| Planned — Approximate Date | ||||
4/8/2026 | 26.12K | $450.6K | NASDAQ | Planned |
| Total | 51.96K | $918.0K | ||